These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 6167541)

  • 21. HLA antigens and Adamantiades-Behçet's disease (A-BD) in Greeks.
    Zervas J; Vayopoulos G; Sakellaropoulos N; Kaklamanis P; Fessas P
    Clin Exp Rheumatol; 1988; 6(3):277-80. PubMed ID: 3180547
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Description of monoclonal antibody defining an HLA allotypic determinant that includes specificities within the B5 cross-reacting group.
    Haynes BF; Reisner EG; Hemler ME; Strominger JL; Eisenbarth GS
    Hum Immunol; 1982 Jul; 4(4):273-85. PubMed ID: 6181035
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The association of HLA-B5 antigen with specific manifestations of Behçet's disease.
    Azizleri G; Aksungur VL; Sarica R; Akyol E; Ovül C
    Dermatology; 1994; 188(4):293-5. PubMed ID: 8193403
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A serological study of the HLA-B17 cross-reactive group.
    Darke C
    Tissue Antigens; 1984 Mar; 23(3):141-50. PubMed ID: 6203186
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Usefulness of the HLA-B5 system in Behçet's disease. Apropos of 93 typed cases].
    Wechsler B; Le Thi Huong Du; Cabane J; Godeau P
    Presse Med; 1984 Feb; 13(5):285. PubMed ID: 6229783
    [No Abstract]   [Full Text] [Related]  

  • 26. [The relationship of the HLA antigen system to Behçet's disease].
    Golosenko IIu
    Vestn Dermatol Venerol; 1990; (5):55-7. PubMed ID: 2402945
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [The HLA pattern in Adamantiades-Behçet's disease in Germany. Association of occurrence, clinical symptoms and follow-up in 39 patients].
    Zouboulis CC; Büttner P; Djawari D; Kirch W; Keitel W; Garbe C; von Keyserlingk-Eberius HJ; Orfanos CE
    Hautarzt; 1993 Feb; 44(2):81-5. PubMed ID: 8449698
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The prevalence of Behçet's syndrome in a rural area in northern Turkey.
    Yurdakul S; Günaydin I; Tüzün Y; Tankurt N; Pazarli H; Ozyazgan Y; Yazici H
    J Rheumatol; 1988; 15(5):820-2. PubMed ID: 3172095
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [The prevalence of HLA-B5 antigen in Behçet's disease].
    Hamza M; Ben Ayed H; Sohier R; Betuel H
    Nouv Presse Med; 1978 Oct; 7(36):3263. PubMed ID: 733499
    [No Abstract]   [Full Text] [Related]  

  • 30. Familial cases of Behcet's disease.
    Dündar SV; Gençalp U; Simşek H
    Br J Dermatol; 1985 Sep; 113(3):319-21. PubMed ID: 4063168
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Close association of HLA-B51 and B52 in Israeli patients with Behçet's syndrome.
    Arber N; Klein T; Meiner Z; Pras E; Weinberger A
    Ann Rheum Dis; 1991 Jun; 50(6):351-3. PubMed ID: 2059078
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cross-reacting xenoantibodies to human and murine beta 2-microglobulin.
    Callahan GN; Ng A; Pellegrino MA; Ferrone S
    Transplant Proc; 1979 Dec; 11(4):1739-42. PubMed ID: 93798
    [No Abstract]   [Full Text] [Related]  

  • 33. A strong association between HLA-B*5101 and Behçet's disease in Greek patients.
    Mizuki N; Ohno S; Ando H; Chen L; Palimeris GD; Stavropoulos-Ghiokas E; Ishihara M; Goto K; Nakamura S; Shindo Y; Isobe K; Ito N; Inoko H
    Tissue Antigens; 1997 Jul; 50(1):57-60. PubMed ID: 9243757
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The combined use of HLA-B5 and the pathergy test as diagnostic markers of Behçet's disease in Turkey.
    Yazici H; Tuzun Y; Pazarli H; Yalcin B; Yurdakul S; Muftuoglu A
    J Rheumatol; 1980; 7(2):206-10. PubMed ID: 7373623
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Different cross-reacting circulating immune complexes in Behçet's syndrome and recurrent oral ulcers.
    Burton-Kee JE; Mowbray JF; Lehner T
    J Lab Clin Med; 1981 Apr; 97(4):559-67. PubMed ID: 7205064
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Peptide motifs of HLA-B51, -B52 and -B78 molecules, and implications for Behćet's disease.
    Falk K; Rötzschke O; Takiguchi M; Gnau V; Stevanović S; Jung G; Rammensee HG
    Int Immunol; 1995 Feb; 7(2):223-8. PubMed ID: 7734418
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Circulating immune complexes in Behçet's syndrome: purification, characterization and cross-reactivity studies.
    Valesini G; Picardo M; Pastore R; Pivetti P; Serafini U
    Clin Exp Immunol; 1981 Jun; 44(3):522-7. PubMed ID: 6976862
    [TBL] [Abstract][Full Text] [Related]  

  • 38. HLA antigens in a Japanese family with Behçet's disease.
    Hayasaka S; Kurome H; Noda S
    Graefes Arch Clin Exp Ophthalmol; 1994 Oct; 232(10):589-90. PubMed ID: 8001828
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Association of class I HLA antigens with the clinical manifestations of Turkish patients with Behçet's disease.
    Kaya TI; Dur H; Tursen U; Gurler A
    Clin Exp Dermatol; 2002 Sep; 27(6):498-501. PubMed ID: 12372094
    [TBL] [Abstract][Full Text] [Related]  

  • 40. HLA antigens in Behçet's disease: a reappraisal by a comparative study of Turkish and British patients.
    Yazici H; Chamberlain MA; Schreuder I; D'Amaro J; Muftuoglu M
    Ann Rheum Dis; 1980 Aug; 39(4):344-8. PubMed ID: 7436560
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.